摘要

Authors' objectives: HTW aimed to identify and summarise evidence that addressed the following question: what is the clinical and cost effectiveness of percutaneously implanted pulmonary artery pressure sensors plus guideline-directed monitoring of chronic heart failure, compared to guideline-directed monitoring alone?